UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000025549
Receipt number R000029389
Scientific Title Study for pathophysiology and diagnostics of mental disorders using MRI
Date of disclosure of the study information 2017/01/05
Last modified on 2017/01/05 19:21:30

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study for pathophysiology and diagnostics of mental disorders using MRI

Acronym

Study for pathophysiology and diagnostics of mental disorders using MRI

Scientific Title

Study for pathophysiology and diagnostics of mental disorders using MRI

Scientific Title:Acronym

Study for pathophysiology and diagnostics of mental disorders using MRI

Region

Japan


Condition

Condition

schizophrenia, manic-depressive disorder etc.

Classification by specialty

Psychiatry Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Claryfying pathophysiology and developing diagnostic markers of mental disorders including schizophrenia

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

(1)MRI:
activation study, resting state MRI, DTI, MRS
(2)behavioral experiments:
Sense of agency task (Keio method)
Temporal order judgment task (Keio method)

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

60 years-old >

Gender

Male and Female

Key inclusion criteria

schizophrenia, depression, Mania, bipolar disorder(diagnosed by DSM4 or 5, ICD-10)

Key exclusion criteria

(1)patients who are in severe mental states
(2)Patients with severe physical illnesses

Target sample size

200


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Takaki Maeda

Organization

Komagino Hospital

Division name

Center for Psychiatry and Behavioral Science

Zip code


Address

273 Uratakao-cho, Hachioji-shi, Tokyo, Japan

TEL

042-663-2222

Email

takaki@keio.jp


Public contact

Name of contact person

1st name
Middle name
Last name Takaki Maeda

Organization

Komagino Hospuital

Division name

Center for Psychiatry and Behavioral Science

Zip code


Address

273 Uratakao-cho, Hachioji-shi, Tokyo, Japan

TEL

042-663-2222

Homepage URL


Email

takaki@keio.jp


Sponsor or person

Institute

Komagino Hospital

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

駒木野病院(東京都)


Other administrative information

Date of disclosure of the study information

2017 Year 01 Month 05 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Date of protocol fixation

2014 Year 12 Month 27 Day

Date of IRB


Anticipated trial start date

2014 Year 12 Month 27 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

We intended crosssectional and longitudinal study of self-disturbances( abnormal sense of agency) in schizophrenia, using MRI(activation study, resting MRI, DTI, MRS).


Management information

Registered date

2017 Year 01 Month 05 Day

Last modified on

2017 Year 01 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029389


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name